Walleye Capital LLC Johnson & Johnson Call Options Transaction History

Walleye Capital LLC

$46.2 Billion
Q3 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$145.48 - $167.38 $3.49 Million - $4.02 Million	24,000 Added 18.76%	151,900 $24.6 Million
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $16.3 Million - $17.8 Million	113,100 Added 764.19%	127,900 $18.7 Million
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $10.2 Million - $10.7 Million	-66,000 Reduced 81.68%	14,800 $2.34 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $844,480 - $921,504	-5,800 Reduced 6.7%	80,800 $12.7 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $13.6 Million - $15.3 Million	-87,500 Reduced 50.26%	86,600 $13.5 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $22.6 Million - $24.4 Million	146,600 Added 533.09%	174,100 $28.8 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $1.65 Million - $1.96 Million	-10,900 Reduced 28.39%	27,500 $4.26 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $1.46 Million - $1.64 Million	9,100 Added 31.06%	38,400 $6.78 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $4.73 Million - $5.26 Million	29,300 New	29,300 $4.79 Million
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $64,405 - $77,755	-500 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $6.22 Million - $8.62 Million	-56,000 Reduced 99.12%	500 $66,000
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $3.88 Million - $4.45 Million	-30,400 Reduced 34.98%	56,500 $8.24 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $9.31 Million - $10.4 Million	73,300 Added 538.97%	86,900 $11.2 Million
Q2 2019 Aug 14, 2019	BUY	$131.15 - $144.24 $655,750 - $721,200	5,000 Added 58.14%	13,600 $1.89 Million
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $1.08 Million - $1.2 Million	8,600 New	8,600 $1.2 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account